Results 321 to 330 of about 60,909 (346)
Some of the next articles are maybe not open access.

Hereditäre Transthyretin-Amyloidosen

Der Nervenarzt, 2014
Hereditary amyloidosis is an autosomal dominant fatal multisystem disease caused by extracellular deposition of misfolded proteins and, therefore represents a hereditary protein folding or deposition disease that leads to progressive organ damage and eventually death.
openaire   +3 more sources

Transthyretin Mass Determination for Detection of Transthyretin Familial Amyloid

2009
The concentration range of plasma proteins exceeds the dynamic range of any single analytical method. It has been estimated that the concentration range of serum proteins exceeds ten orders of magnitude (1). Because of this, prior immunoselection of even abundant proteins facilitates the relative nonquantitative observations required to show structural
John F. O'Brien, H. Robert Bergen
openaire   +3 more sources

Transthyretin and the Transthyretin Amyloidoses

2007
Transthyretin is a normal serum protein that carries the secondary thyroid hormone thyroxine and retinol binding protein when it is loaded with retinol. It is synthesized primarily in the liver but there is also significant production in the choroid plexus and the retina. Both message and protein are found in the kidney but that site does not appear to
openaire   +2 more sources

Monoclonal antibodies to transthyretin

Scandinavian Journal of Clinical and Laboratory Investigation, 1986
Monoclonal antibodies (mabs) have been raised against human transthyretin (hTTR). The protein was isolated by an affinity chromatography procedure using Sepharose-hRBP and BALB/c mice were immunized. Following fusion with SP 2/0 myeloma cells, 26 single cell clones producing antibodies against hTTR were isolated.
Tom Pettersson   +3 more
openaire   +3 more sources

Cardiac transthyretin amyloidosis

Heart, 2012
Cardiac amyloidosis of transthyretin fibril protein (ATTR) type is an infiltrative cardiomyopathy characterised by ventricular wall thickening and diastolic heart failure. Increased access to cardiovascular magnetic resonance imaging has led to a marked increase in referrals to our centre of Caucasian patients with wild-type ATTR (senile systemic ...
Jason Dungu   +3 more
openaire   +2 more sources

Pathogenesis of transthyretin amyloidosis

Amyloid, 2012
Current dogma for transthyretin (TTR) pathogenesis is that mutations in TTR alter its structure such that the tetramer becomes unstable and prone to release of monomer which then becomes the putative building block of the fibril. This hypothesis is supported by thermodynamic data showing decreased stability of mutant TTR tetrameric proteins and ...
openaire   +2 more sources

Tafamidis: A First-in-Class Transthyretin Stabilizer for Transthyretin Amyloid Cardiomyopathy

Annals of Pharmacotherapy, 2019
Objective: To review the pharmacology, efficacy, and safety of the selective transthyretin inhibitor tafamidis for transthyretin amyloid cardiomyopathy (ATTR-CM). Data Sources: A PubMed (1966 to October 2019) and ClinicalTrials. gov search was conducted using the keywords tafamidis, Fx-1006A, Vyndaqel, and Vyndamax.
Jonathan Park   +5 more
openaire   +2 more sources

Localization of transthyretin-mRNA and of immunoreactive transthyretin in the human fetus

Virchows Archiv A Pathological Anatomy and Histopathology, 1989
Five human fetuses at mid-term (16-20 weeks) and one with a gestational age of 8 weeks were investigated. The cellular localization of transthyretin (TTR)-mRNA in different organs was demonstrated by in situ hybridization with a 35S-labelled, single-stranded RNA probe. Immunoreactive TTR (TTR-IR) was localized with a monoclonal antibody to TTR.
openaire   +3 more sources

Tafamidis for transthyretin amyloidosis

Drugs of Today, 2012
Tafamidis meglumine (Vyndaqel®, Pfizer) is a novel, first-in-class drug for the treatment of transthyretin familial amyloid polyneuropathy (TTR-FAP), a rare neurodegenerative disorder characterized by progressive sensory, motor and autonomic impairment that is ultimately fatal.
openaire   +3 more sources

Transthyretin Genetic Testing

JAMA Cardiology, 2021
Sadiya S. Khan   +2 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy